Pharnext (FR:ALPHA) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Pharnext SCA, a biopharmaceutical company focused on neurodegenerative diseases, has initiated liquidation proceedings after failing to secure funding post-conciliation. The Paris Commercial Court has appointed a liquidator and trading of Pharnext’s shares has been suspended. Shareholders are unlikely to receive any payment from asset sales due to the company’s liabilities and are warned of potential capital loss and share dilution.
For further insights into FR:ALPHA stock, check out TipRanks’ Stock Analysis page.
